Areas of interest
- Developing novel cannabinoid-based therapies for onco-metabolic and neurodegenerative diseases
- Identifying multi-modal molecules that selectively target the endocannabinoid system
- Validation of new combinatorial cannabinoid-based antitumor therapies
- Elucidating the role of mitochondrial dysfunction in various pathological contexts, particularly its connection to cannabinoid receptors